It’s worth noting that the expression of PD-1 and its ligand PD-L1 is upregulated upon T cell activation (62), and their interaction inhibits T cell activity, thereby hindering the attack of cytotoxic T lymphocytes (CTL) on tumor cells, leading to CTL dysfunction and immune escape (63). The gene discussed is CD274; the disease is neoplasm.